Evidences of CTLA-4 and PD-1 Blocking Agents-Induced Cardiotoxicity in Cellular and Preclinical Models
Vincenzo Quagliariello(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Nicola Maurea(Cancer Institute (WIA)), Gerardo Botti(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Margherita Passariello(Federico II University Hospital), Antônio Barbieri, Claudia De Lorenzo(Istituto Nazionale di Fisica Nucleare, Sezione di Napoli), Domenica Rea(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Antonietta Caronna(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Martina Iovine(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Annamaria Bonelli(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale")
Cited by 68
Related Papers
Cancer classification using the Immunoscore: a worldwide task force
|Journal of Translational Medicine|2012|803
<i>BRAF/NRAS</i> Mutation Frequencies Among Primary Tumors and Metastases in Patients With Melanoma
|Journal of Clinical Oncology|2012|460
The SGLT-2 inhibitor empagliflozin improves myocardial strain, reduces cardiac fibrosis and pro-inflammatory cytokines in non-diabetic mice treated with doxorubicin
|Cardiovascular Diabetology|2021|368
Basic principles of biobanking: from biological samples to precision medicine for patients
|Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin|2021|223